Norit (Charcoal, Activated)

Activated charcoal has a highly porous surface that physically adsorbs a broad spectrum of organic compounds. When administered orally, it binds toxins, gases and liquids in the gastrointestinal lumen through hydrophobic and van der Waals forces, forming a complex that is not absorbed and is eliminated in the feces.

The dose of Norit is determined by the prescribing healthcare professional based on the type and amount of toxin ingested, the patient’s age, weight and clinical condition. No fixed regimen is provided here; clinicians calculate the appropriate amount for each individual case.

Safety data for activated charcoal in pregnancy and lactation are limited. It should only be used when clearly needed and after a risk‑benefit assessment by a qualified healthcare provider. Women who are pregnant or breastfeeding should discuss potential risks with their physician before use.

To order Norit, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Norit (activated charcoal) is a non‑specific adsorbent that can bind many different toxins, whereas some alternatives, such as specific antidotes, target only particular poisons. Compared with other charcoal products, Norit offers the same mechanism of action; choice often depends on formulation, availability and local practice guidelines.

Store Norit at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme heat. Keep it out of reach of children and ensure the container is tightly sealed after each use to maintain product integrity.

Norit is administered orally as a powder. The recommended practice is to mix the measured amount of powder with a small volume of water or another suitable liquid, stir to a uniform suspension, and have the patient drink it promptly. Administration should occur as soon as possible after toxin ingestion.

The most serious risks include aspiration of the charcoal into the lungs, which can cause pneumonia, and bowel obstruction or fecal impaction from accumulated charcoal. Rarely, severe allergic reactions may occur. Patients should be monitored for respiratory distress, abdominal pain or signs of obstruction.

Norit should be avoided in patients with an unprotected airway, reduced consciousness without airway support, suspected gastrointestinal perforation or obstruction, and in those who are allergic to activated charcoal. It is also contraindicated when the risk of aspiration outweighs the potential benefit.